Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Respiratory care in muscular dystrophy

View through CrossRef
Abstract Respiratory problems are a major cause of morbidity and mortality in the muscular dystrophies. Indeed, in Duchenne muscular dystrophy (DMD) respiratory complications are the cause of death in over 70 per cent of patients, and virtually all Duchenne patients will develop ventilatory insufficiency if they survive long enough. In the other muscular dystrophies the extent of respiratory compromise will depend on the degree of respiratory muscle involvement, the presence of a thoracic scoliosis and level of bulbar weakness. In congenital muscular dystrophy merosin negative individuals seem more prone to early respiratory failure than merosin positive patients. Ventilatory failure is relatively uncommon, although not unknown in facioscapulohumeral muscular dystrophy, and has a variable prevalence in limb girdle MD. Although ventilatory support has been used sporadically in neuromuscular patients with chronic ventilatory failure for over 50 years, in the last decade the use of non-invasive ventilation has had a significant impact on survival and long-term outcome, particularly in DMD patients. In this chapter the natural history of respiratory problems in the muscular dystrophies is discussed, with particular emphasis on monitoring, identifying high-risk patients, and the outcome of therapeutic interventions.
Title: Respiratory care in muscular dystrophy
Description:
Abstract Respiratory problems are a major cause of morbidity and mortality in the muscular dystrophies.
Indeed, in Duchenne muscular dystrophy (DMD) respiratory complications are the cause of death in over 70 per cent of patients, and virtually all Duchenne patients will develop ventilatory insufficiency if they survive long enough.
In the other muscular dystrophies the extent of respiratory compromise will depend on the degree of respiratory muscle involvement, the presence of a thoracic scoliosis and level of bulbar weakness.
In congenital muscular dystrophy merosin negative individuals seem more prone to early respiratory failure than merosin positive patients.
Ventilatory failure is relatively uncommon, although not unknown in facioscapulohumeral muscular dystrophy, and has a variable prevalence in limb girdle MD.
Although ventilatory support has been used sporadically in neuromuscular patients with chronic ventilatory failure for over 50 years, in the last decade the use of non-invasive ventilation has had a significant impact on survival and long-term outcome, particularly in DMD patients.
In this chapter the natural history of respiratory problems in the muscular dystrophies is discussed, with particular emphasis on monitoring, identifying high-risk patients, and the outcome of therapeutic interventions.

Related Results

Advanced Physiotherapy Intervention for Muscular Dystrophy
Advanced Physiotherapy Intervention for Muscular Dystrophy
Muscular dystrophies are rare neuromuscular conditions which are genetically and clinically diverse that cause gradual, progressive weakness and breakdown of skeletal muscles over ...
Duchene’s muscular dystrophy: a clinical case
Duchene’s muscular dystrophy: a clinical case
Background. Muscular dystrophy is a heterogeneous group of genetic disorders characterized by progressive loss of skeletal muscles. Duchene's muscular dystrophy (MDD) is one of the...
Clinico-pathological Diagnosis of Facioscapulohumeral Dystrophy in a 22-year-old Male
Clinico-pathological Diagnosis of Facioscapulohumeral Dystrophy in a 22-year-old Male
Background: Facioscapulohumeral dystrophy (FSHD) is a rare hereditary disease with a prevalence of 2.03–6.8 per 100,000 individuals. FSHD is the third most common type of muscular ...
An Automated Identification of Muscular Atrophy and Muscular Dystrophy Disease in Fetus using Deep Learning Approach
An Automated Identification of Muscular Atrophy and Muscular Dystrophy Disease in Fetus using Deep Learning Approach
Muscular Atrophy (MA) and Muscular dystrophy (MD) diseases are genetic diseases. These diseases are commonly diagnosed with the help of techniques such as chorionic villus sampling...
A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy
A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy
Abstract A novel canine muscular dystrophy in Landseer dogs was observed. We had access to five affected dogs from two litters. The clinical signs started at a few w...
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Role of Growth Factors and Apoptosis Proteins in Cognitive Disorder Development in Patients with Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease; it occurs due to a mutation in the dystrophin protein gene; as a result, the protein is not synthesized an...
The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity
The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity
It is well known that muscular dystrophy disease severity is controlled by genetic modifiers. The expectation is that by identifying these modifiers, we can illuminate additional t...
Cell Therapy for Muscular Dystrophy
Cell Therapy for Muscular Dystrophy
Muscular dystrophy is a major unmet medical need associated with an inevitable progressive muscle damage and loss of function. Currently, treatment is only symptomatic and supporti...

Back to Top